We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

0UNL Nektar Therapeutics

0.00 (0.0%)
Last Updated: 00:00:00
Delayed by 15 minutes

Nektar Therapeutics Financial Summary

The current 0UNL market cap is 9B. The company's latest EPS is USD -1.9301 and P/E is -0.24.

Year End 31 December 2022 20182019202020212022
Total Revenue 1.19B114.62M152.92M101.91M92.06M
Operating Income 687.93M-440.04M-379.92M-446.1M-313.73M
Net Income 681.31M-440.67M-444.44M-523.84M-368.2M
Year End 31 December 2022 20182019202020212022
Total Assets 2.15B1.98B1.54B1.12B710.6M
Total Liabilities 432.6M571.97M461.47M437.68M343.96M
Total Equity 1.72B1.41B1.08B679.51M366.64M

Cash Flow

Year End 31 December 2022 20182019202020212022
Operating 718.21M-328.68M-313.29M-412.66M-304.01M
Investing -1.38B206.89M496.21M202.78M365.84M
Financing 851.97M23.36M-80.35M36.24M1.51M
Market Cap 9B
Price to Earnings Ratio -0.24
Price to Sales Ratio 0.97
Price to Cash Ratio 1.02
Price to Book Ratio 0.24
Dividend Yield -

Share Statistics

Shares Outstanding 190.77M
Average Volume (1 week) 8.05k
Average Volume (1 Month) 13.48k
52 Week Change 0.0%
52 Week High 47.18
52 Week Low 47.18
Spread (Intraday) 0 (0%)

Company Info

Company Name Nektar Therapeutics
Address 1209 orange street
wilmington, delaware 19801
Industry pharmaceutical preparations (2834)

Your Recent History

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 |